Skip to main content
. 2023 Feb 22;80(4):371–379. doi: 10.1001/jamapsychiatry.2022.5164

Table 2. Psychotic and Negative Symptoms and Global Functional Levels at 1, 2, 5, 10, and 20 Years After Randomization.

Follow-up Mean (SE) Estimated mean difference (95% CI) P value of difference
OPUS TAU
Psychotic symptom dimensiona
1 y 1.10 (0.08) 1.40 (0.09) −0.30 (−0.54 to −0.06) .02
2y 1.04 (0.09) 1.38 (0.10) −0.34 (−0.60 to −0.08) .01
5 y 1.39 (0.12) 1.30 (0.12) 0.09 (−0.24 to 0.43) .58
10 y 1.17 (0.10) 1.17 (0.11) 0.00 (−0.29 to 0.29) .99
20 y 1.35 (0.14) 1.21 (0.14) 0.14 (−0.25 to 0.52) .48
Negative symptom dimensionb
1 y 1.71 (0.07) 2.06 (0.07) −0.35 (−0.53 to −0.16) .001
2 y 1.42 (0.08) 1.87 (0.08) −0.45 (−0.67 to −0.23) .001
5 y 1.70 (0.10) 1.76 (0.10) −0.06 (−0.34 to 0.23) .69
10 y 1.55 (0.08) 1.47 (0.08) 0.08 (−0.14 to 0.29) .49
20 y 1.82 (0.11) 1.69 (0.11) 0.13 (−0.18 to 0.44) .41
GAF functionc
1 y 51.74 (0.89) 49.42 (0.93) 2.32 (−0.21 to 4.85) .07
2y 54.89 (0.98) 52.23 (1.04) 2.66 (−0.13 to 5.45) .06
5 y 53.34 (1.24) 53.28 (1.26) 0.05 (−3.41 to 3.52) .98
10 y 53.24 (1.15) 53.97 (1.19) −0.73 (−3.99 to 2.52) .66
20 y 51.97 (1.40) 55.69 (1.43) −3.72 (−7.67 to 0.22) .06

Abbreviations: OPUS, intensive early intervention program; TAU, treatment as usual.

a

Based on the scale for Assessment for Positive Symptoms.25

b

Based on the scale for Assessment of Negative Symptoms.26

c

Based on the Global Assessment of Functioning (GAF) scale.27